INTERNSHIP DETAILS

Trainee (Inclusion of elderly patients in pivotal clinical trials supporting cancer indications)

CompanyEMA
LocationAmsterdam
Work ModeOn Site
PostedApril 10, 2026
Internship Information
Core Responsibilities
The trainee will review available data supporting regulatory approvals, focusing on data in older patients for selected cancer types, and compare this with current epidemiological data. Additionally, the role involves leveraging the existing oncology scientific memory database by integrating information from multiple sources to support future assessments and enhance evidence-based benefit-risk assessments.
Internship Type
full time
Company Size
1687
Visa Sponsorship
No
Language
English
Working Hours
40 hours
Apply Now →

You'll be redirected to
the company's application page

About The Company
The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.
About the Role

Selection procedure reference: EMA/TR/11367 

Deadline for applications: 06 May 2026 23:59 CET 

 

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.

 

This traineeship opportunity is now open for applications until 06 May 2026 23:59 CET, with an intake on 1 October 2026.

About the traineeship programme

The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.

Placement description

We are looking for a trainee in the Oncology and radiopharmaceuticals Office.

Specific objectives and projects

1 – In the context of an ageing cancer patient population, the trainee will review the available data supporting regulatory approvals, with a specific focus on data in older patients for selected cancer types, and compare these with current epidemiological data.
 
2 – Leverage the existing oncology scientific memory database by integrating information from multiple sources to support future assessments and further enhance the quality of outputs and evidence-based benefit-risk assessments.

Learning outcomes

Through this project, the trainee will:
  • develop knowledge of challenges related to clinical development in oncology;
  • gain insight into the evaluation of human medicines and benefit-risk assessment, particularly in the area of solid tumours;
  • understand the roles of the various stakeholders involved in the evaluation of human medicines;
  • further develop reporting and communication skills.

Eligibility criteria

To be eligible for consideration for this placement, you are required to:

  1. enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
  2. possess a university degree in pharmacy, medicine or life sciences (minimum of three years or more) that must have been obtained between 6 May 2025 and 6 May 2026 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
  3. a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages

 

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.

Additional skills

In addition to the eligibility criteria, you will have:
  • analytical skills
  • communication skills 

Behavioural Competencies

You will demonstrate the following behavioural competencies:

  • Communication skills
  • Interpersonal skills
  • Working with others
  • Adaptability
  • Research and analytical skills
  • Learning and development

Conditions of traineeship

The traineeship is offered for 10 months (1 October 2026 – 31 July 2027) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.

The Agency pays a monthly stipend of €2,049.77 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.

Each trainee will have a mentor at the Agency who will guide the trainee through the programme.

The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.

Expected selection timelines

Deadline for applications 06 May 2026 23:59 CET 
Assessments (remote)From mid-June 2026 to mid-July 2026
Decision and offers By end of July 2026
Placement start 1 October 2026

 

______________________________________________________________________________________________________

Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands

Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu

 

© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.

Key Skills
Analytical SkillsCommunication SkillsInterpersonal SkillsAdaptabilityResearchLearning And DevelopmentReporting Skills
Categories
Science & ResearchHealthcareLegalGovernment & Public Sector
Benefits
Travel ContributionMentor